ArticleCureus2025
Advanced, Recurrent Malignant Phyllodes Tumor With Malignant Heterologous Osteoid Differentiation Coexisting With Fibroadenoma in a 17-Year-Old Female Nigerian: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibroepithelial tumors of the breast are characterized by neoplastic proliferations of both ductal epithelial and stromal components of the breast parenchyma and exhibit biological behavior that ranges from completely benign to frankly malignant subtypes. Fibroadenoma, the prototypical benign example of these tumors, is both the most common benign tumor of the female breast overall and the most common breast tumor in adolescent and young adult females. Phyllodes tumor, on the other hand, encapsulates the full spectrum of benign to malignant biological behavior of these tumors, and while not as prevalent as fibroadenoma, it nevertheless occurs over a wider age range and is more prevalent in older females. The age incidence of phyllodes tumor also parallels its biological behavior, increasing as the spectrum progresses from benign to malignant. Fibroadenoma and phyllodes tumor share clinical and morphological characteristics, although they arise from different components of the breast parenchyma, the terminal duct lobular unit, and specialized periductal stroma. Furthermore, the malignant potential of phyllodes tumor makes its diagnostic distinction from fibroadenoma a clinical and prognostic imperative. We present the unusual case of a 17-year-old adolescent female, Nigerian, who was diagnosed with malignant phyllodes tumor of the left breast, with heterologous osteoid component, coexisting with an ipsilateral fibroadenoma, highlighting the importance of proper evaluation of breast masses regardless of patients' age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.